Publication dates

All regions

Erythropoietin Industry, July 2014 Market Research & Statistics

You might be interested in: drug, biosimilar, medicine, more »

1-10 of about 300 reports for Erythropoietin

Biosimilars Forecast Statistics in Europe

  • Analysis of European Biosimilars Market
  • January 2012
    26 pages
  • Biosimilars  

  • Europe  

    World  

View report >

Pathology Description in Japan

  • Visualizing Ourpotential
  • January 2012
    18 pages
  • Pathology  

  • Japan  

View report >

General Medicine And Specialty Medicine Markets

  • Outpatient Dialysis Services Payment system
  • January 2014
    4 pages
  • Payment Process...  

    Payment System  

View report >

France - Economic Analysis

  • Mortality of French Participants in the Tour de France (1947 - 2...
  • September 2013
    6 pages
  • France  

    Europe  

View report >

Medicine Markets in the US

  • The Use of Medicines in the United States: Review of 2011
  • April 2012
    46 pages
  • Medicine  

  • United States  

View report >

Medicine Markets in the US

  • The Use of Medicines in the United States: Review of 2011
  • April 2012
    46 pages
  • Medicine  

  • United States  

View report >

Medicine Markets in the US

  • The Use of Medicines in the United States: Review of 2011
  • April 2012
    46 pages
  • Medicine  

  • United States  

View report >

Allograft Statistics

  • January 2012
    10 pages
  • Allograft  

    Transplantation  

    Specialty Surge...  

  • Turkey  

    United States  

View report >

Kidney Transplantation Expenditures in the US

  • Medicare Immunosuppressive Drug Coverage for Kidney Transplant R...
  • July 2013
    12 pages
  • Kidney Transpla...  

    Transplantation  

  • United States  

View report >

Insulin Industry in India and the US - Forecast

  • Fy2012e ? Buy
  • January 2014
    31 pages
  • Insulin  

  • India  

    United States  

    Europe  

View report >
21 reports for Erythropoietin

Purchase Reports From Reputable Market Research Publishers
(From $ 63 - $ 10 000)

Vital Signs - Healthcare News - The Analyst%s Perspective - May Issue

Vital Signs - Healthcare News - The Analyst%s Perspective - May Issue

  • $ 450
  • Industry report
  • June 2014
  • by Frost & Sullivan

This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagen's ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.